Lantern Pharma's total assets for Q1 2025 were $21.10M, a decrease of -17.50% from the previous quarter. LTRN total liabilities were $4.32M for the fiscal quarter, a -1.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.